Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status

Fig. 1

Relapse-free survival (RFS) of Mt and Wt patients did not differ (p = 0.907, (a)). The RFS of Mt high-risk patient was significantly worse than Mt low-risk patients (36.5% vs. 81.8%, p < 0.001, (b)). The RFS of Wt high-risk patients was significantly worse than Wt low-risk patients (44.6% vs. 73.3%, p < 0.001, (c))

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us